BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 9651733)

  • 1. Role of sympathetic nervous system in hypertension and effects of cardiovascular drugs.
    Noll G; Wenzel RR; Binggeli C; Corti C; Lüscher TF
    Eur Heart J; 1998 Jun; 19 Suppl F():F32-8. PubMed ID: 9651733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Sympathy and heartache: new information on the sympathetic nervous system].
    Spieker LE; Binggeli C; Lüscher TF; Noll G
    Schweiz Med Wochenschr; 1997 Nov; 127(48):1986-92. PubMed ID: 9490465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High blood pressure management: potential benefits of I1 agents.
    Esler M
    J Hypertens Suppl; 1998 Aug; 16(3):S19-24. PubMed ID: 9747906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium antagonists and sympathetic nerve activation: are there differences between classes?
    Noll G; Wenzel RR; Shaw S; Lüscher TF
    J Hypertens Suppl; 1998 Jan; 16(1):S17-24. PubMed ID: 9534092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications.
    Triposkiadis F; Karayannis G; Giamouzis G; Skoularigis J; Louridas G; Butler J
    J Am Coll Cardiol; 2009 Nov; 54(19):1747-62. PubMed ID: 19874988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of hypertension in renal failure: role of the sympathetic nervous system and renal afferents.
    Phillips JK
    Clin Exp Pharmacol Physiol; 2005; 32(5-6):415-8. PubMed ID: 15854151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The sympathetic nervous system in the pathogenesis of hypertension.
    Rahn KH; Barenbrock M; Hausberg M
    J Hypertens Suppl; 1999 Aug; 17(3):S11-4. PubMed ID: 10489093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal hemodynamics and cardiovascular reactivity in the prehypertensive stage.
    Schmieder RE; Rüddel H; Schächinger H; Bruns J; Schulte W
    Behav Med; 1993; 19(1):5-12. PubMed ID: 8219530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of antihypertensive therapies on the sympathetic nervous system.
    de Champlain J; Karas M; Toal C; Nadeau R; Larochelle P
    Can J Cardiol; 1999 Mar; 15 Suppl A():8A-14A. PubMed ID: 10205251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sympathetic nervous factors, pressure variability and organ damage in arterial hypertension].
    Mancia G; Seravalle G; Grassi G
    Ann Ital Med Int; 1997; 12(4):217-22. PubMed ID: 9773576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of angiotensin II in sympathetic nervous system induced left ventricular dysfunction.
    Bosso FJ; Jarjoura DG; Pilati CF
    Can J Physiol Pharmacol; 1999 Oct; 77(10):806-12. PubMed ID: 10588485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of antihypertensive therapy on sympathetic nervous system activity in patients with essential hypertension.
    Chernow B; Zaloga GP; Lake CR; Coleman MD; Ziegler MG
    Fed Proc; 1984 Jan; 43(1):72-7. PubMed ID: 6317467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The sympathetic nervous system in hypertension: differing effects of drug treatment.
    Sleight P
    Eur Heart J; 1998 Jun; 19 Suppl F():F39-44. PubMed ID: 9651734
    [No Abstract]   [Full Text] [Related]  

  • 14. Regulation of sympathetic nerve activity in mild human hypertension.
    Mark AL
    J Hypertens Suppl; 1990 Dec; 8(7):S67-75. PubMed ID: 1965657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exercise training and sympathetic nervous system activity: evidence for physical activity dependent neural plasticity.
    Mueller PJ
    Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):377-84. PubMed ID: 17324153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenergic activity and myocardial anatomy and function in essential hypertension.
    Muiesan G; Agabiti-Rosei E; Muiesan ML
    J Hypertens Suppl; 1985 Dec; 3(4):S45-50. PubMed ID: 3007705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological mechanism of angiotensin II receptor antagonists: implications for the treatment of elevated systolic blood pressure.
    Brooks DP; Ruffolo RR
    J Hypertens Suppl; 1999 Jun; 17(2):S27-32. PubMed ID: 10465064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation in the effects of the angiotensin II receptor blocker class on autonomic function.
    Esler M
    J Hypertens Suppl; 2002 Jun; 20(5):S13-9. PubMed ID: 12184059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive drugs and the sympathetic nervous system.
    Del Colle S; Morello F; Rabbia F; Milan A; Naso D; Puglisi E; Mulatero P; Veglio F
    J Cardiovasc Pharmacol; 2007 Nov; 50(5):487-96. PubMed ID: 18030057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of sympathetic nervous activity in renal injury and end-stage renal disease.
    Masuo K; Lambert GW; Esler MD; Rakugi H; Ogihara T; Schlaich MP
    Hypertens Res; 2010 Jun; 33(6):521-8. PubMed ID: 20339374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.